Understanding the mechanisms of the eosinophil in COPD is important for research and development, Bafadhel said. Along with standardizing measurement of T2 inflammatory markers (interleukin [IL] 4 ...
They may also help to identify mechanisms responsible for lung destruction in COPD, which in turn could identify new treatment targets that bronchodilators – although a mainstay of therapy ...
COPD comprises several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease affects more than 15 million ...
In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...
(RTTNews) - 2024 has been a banner year for Verona Pharma (VRNA), with its share price surging more than threefold in just 7.5 months. The ...
Hosted on MSN24d
FDA Accepts GSK's Filing for Expanded Use of Nucala in COPDGSK’s Nucala is a monoclonal antibody with a novel mechanism of action that targets ... Currently, the drug is not approved for COPD worldwide. In the past three months, shares of GSK have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback